Free Delivery Over $100
|
|
|||
|
||||
OverviewMyelodysplastic syndromes (MDS) are a group of clonal disorders characterized by pancytopenias and the risk of progression to acute myeloid leukemia. The diagnosis of MDS can be challenging, while the outcomes of MDS patients vary widely. This book provides a concise yet comprehensive overview of MDS. The book begins by reviewing the diagnostic workup of MDS, with a specific focus on the 2016 WHO criteria for MDS diagnosis, and the biology and pathophysiology of the disease. The text then presents the molecular landscape of MDS and its impact on disease diagnosis, prognosis, and treatment decisions. The book continues by profiling different prognostic models of MDS and concludes with a thorough review of treatment algorithms for lower and higher-risk MDS, as well as the use of hematopoietic stem cell transplant to combat the disease. Written by experts in the field, Diagnosis and Management of Myelodysplastic Syndromes: A Clinical Guide is a valuable resource for clinicians, practitioners, and researchers who are interested in MDS. The text also features over 100 illustrations, photographs, and tables. Full Product DetailsAuthor: Aziz NazhaPublisher: Springer Nature Switzerland AG Imprint: Springer Nature Switzerland AG Edition: 1st ed. 2020 Weight: 0.369kg ISBN: 9783030518806ISBN 10: 3030518809 Pages: 179 Publication Date: 15 August 2021 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsEpidemiology, Etiology, and Clinical Presentation of Myelodyplastic Syndromes.- Morphological, Flow Cytometry, and Cytogenetic Diagnosis of MDS.- Biology and Pathophysiology of MDS with del5q.- MDS Stem Cell Biology.- Molecular Landscape of MDS.- MDS Mimics (CHIP, ICUS, CCUS).- Prognostic Models in Myelodyplastic Syndromes.- Treatment Algorithms for Lower-risk Disease.- Treatment Algorithms for Higher-risk Disease.- Hematopoietic Cell Transplantation for MDS Patients.ReviewsThis book will most likely be read by physicians involved in the diagnosis and treatment of myeloid malignancies including MDS, specifically practicing hematologist/oncologists and hematopathologists, as well as by physician trainees in these fields (residents and fellows). ... This is a fantastic book that will be of great benefit to any physician diagnosing and treating patients with myelodysplastic syndromes. (George M Rodgers, Doody's Book Reviews, January 8, 2021) Author InformationAziz Nazha, MDCleveland ClinicDepartment of Hematology and Medical OncologyTaussig Cancer InstituteCleveland, OH USA Tab Content 6Author Website:Countries AvailableAll regions |
||||
